Copper-catalysed C-H functionalisation gives access to 2-aminobenzimidazoles
This paper describes the development, optimisation and exemplification of a copper-catalysed C-H functionalisation to form pharmaceutically relevant 2-aminobenzimidazoles from aryl-guanidines. High throughput screening was used as a tool to identify a catalytically active copper source, DoE was used...
Saved in:
Published in | Organic & biomolecular chemistry Vol. 17; no. 34; pp. 7943 - 7955 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
CAMBRIDGE
Royal Soc Chemistry
28.08.2019
Royal Society of Chemistry |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | This paper describes the development, optimisation and exemplification of a copper-catalysed C-H functionalisation to form pharmaceutically relevant 2-aminobenzimidazoles from aryl-guanidines. High throughput screening was used as a tool to identify a catalytically active copper source, DoE was used for reaction optimisation and a range of aryl-guanidines were prepared and exposed to the optimum conditions to afford a range of 2-aminobenzimidazoles in moderate to good yields. The methodology has been applied to the synthesis of Emedastine, a marketed anti-histamine pharmaceutical compound, with the key cyclisation step performed on a gram-scale.
This paper describes the development, optimisation and exemplification of a copper-catalysed C-H functionalisation to form pharmaceutically relevant 2-aminobenzimidazoles from aryl-guanidines. |
---|---|
Bibliography: | 1 F, and 13 10.1039/c9ob01651a H 19 Electronic supplementary information (ESI) available: Copies of C NMR spectra of all new compounds can be found, along with 1H of known compounds. Results of a high throughput screen of copper sources, additives & solvents, the kinetic isotope effect experiment and the design of experiment optimisation procedure & the statistical model. See DOI ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1477-0520 1477-0539 |
DOI: | 10.1039/c9ob01651a |